# OnCo record csco-guidelines (collection). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/collections/csco-guidelines/>
  a schema:Dataset ;
  onco:kind "collection" ;
  schema:identifier "csco-guidelines" ;
  schema:name "CSCO guidelines (China)"@en ;
  schema:description "CSCO guidelines are China's national oncology guidelines, covering about 30 cancers and updated annually. They grade each recommendation by both evidence level and affordability under China's reimbursement list, and they cover Chinese-developed drugs (PD-1 inhibitors, ADCs) and cancers common in China (nasopharyngeal, oesophageal, liver, gastric) years before Western guidelines."@en ;
  schema:url <https://onco.cc/collections/csco-guidelines/>, <https://www.csco.org.cn/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.csco.org.cn/>, <https://doi.org/10.1200/JCO.20.03237> ;
  onco:tag "gap-fill", "guidelines" ;
  schema:license "CSCO" ;
  onco:related <https://onco.cc/collections/nccn/>, <https://onco.cc/collections/esmo-guidelines/>, <https://onco.cc/cancers/nasopharyngeal/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/gastric/> ;
  onco:drugs <https://onco.cc/drugs/toripalimab/>, <https://onco.cc/drugs/camrelizumab/>, <https://onco.cc/drugs/tislelizumab/>, <https://onco.cc/drugs/penpulimab/> ;
  onco:institutions <https://onco.cc/institutions/sysucc/>, <https://onco.cc/institutions/cams-cancer-hospital/> .